Survey of Inpatients on Integrative Therapy Methods
Patient Survey on Integrative Therapy Methods - a Cross-sectional Study of Hospital Inpatients
1 other identifier
observational
127
1 country
1
Brief Summary
Observational study of general patient satisfaction and inpatients' experiences with integrative therapies. The study recruits inpatients of the Filderklinik, an anthroposophic hospital in southwestern Germany. The aim is to assess overall patient satisfaction and inpatients' experiences with integrative therapies at the Filderklinik.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2022
CompletedFirst Posted
Study publicly available on registry
February 11, 2022
CompletedStudy Start
First participant enrolled
February 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2022
CompletedApril 19, 2023
April 1, 2023
11 months
February 2, 2022
April 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient satisfaction, ZUF-8 total score
Patient satisfaction, measured with the ZUF-8 patient satisfaction questionnaire, a validated questionnaire (German language) with 8 items related to overall patient satisfaction associated with an inpatient hospital stay. Items are rated on 4-point scales from positive to negative (no "neutral" position), with 1 being the least positive and 4 being the most positive value (total scale range 8-32). In the current study, the ZUF-8 is part of the comprehensive "Special Therapy Procedures" questionnaire, which covers all outcome measures not retrieved from the clinic database.
Assessing the entire duration of the hospital stay, an average of 7 days.
Secondary Outcomes (17)
Diagnoses
Assessing the entire duration of the hospital stay, an average of 7 days.
Therapies
Assessing the entire duration of the hospital stay, an average of 7 days.
OPS codings
Assessing the entire duration of the hospital stay, an average of 7 days.
Inpatient admitting department
At the time of admission to the Filderklinik, at the beginning of hospitalization (an average of 7 days).
Integrative therapies according to clinic database
Assessing the entire duration of the hospital stay, an average of 7 days.
- +12 more secondary outcomes
Interventions
Integrative therapy methods used at the Filderklinik, such as music therapy, therapeutic painting, therapeutic sculptural forming, speech therapy, eurythmy therapy, rhythmical massage, external applications, coloured light therapy
Eligibility Criteria
Inpatients of the Filderklinik who have received at least 10 treatments with one or more of the various integrative therapy methods used at the Filderklinik.
You may qualify if:
- Written informed consent
- Filderklinik inpatient who had at least 10 treatments with one ore more of the integrative therapy methods
- Age 18 years or older
You may not qualify if:
- Insufficient German language skills
- Legally incapacitated patients
- Patients who are physically incapable of giving written consent
- Patients in isolation wards
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arcim Institute
Filderstadt, Baden-Wurttemberg, 70794, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jan Vagedes, Dr
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2022
First Posted
February 11, 2022
Study Start
February 15, 2022
Primary Completion
December 29, 2022
Study Completion
December 29, 2022
Last Updated
April 19, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- The data will be made available upon publication for a duration of three months.
- Access Criteria
- The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.
Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.